Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
AGL Agilon Health	$2.13 -1.8%	$2.29	$1.50 ▼ $7.62	$881.71M	0.16	4.71 million shs	3.07 million shs
AIRS AirSculpt Technologies	$5.56 -6.2%	$4.71	$1.53 ▼ $9.20	$326.82M	2.46	298,185 shs	607,462 shs
CDNA CareDx	$11.91 +0.8%	$18.23	$10.96 ▼ $34.84	$663.15M	2.19	1.01 million shs	5.72 million shs
PNTG The Pennant Group	$23.43 -2.0%	$27.79	$21.18 ▼ $37.13	$807.63M	1.51	237,058 shs	393,084 shs

These 7 Stocks Will Be Magnificent in 2025

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
AGL Agilon Health	0.00%	-4.48%	+0.71%	-48.55%	-69.09%
AIRS AirSculpt Technologies	0.00%	+11.65%	+16.56%	+227.06%	+25.51%
CDNA CareDx	0.00%	-40.83%	-37.45%	-29.69%	-34.16%
PNTG The Pennant Group	0.00%	-7.13%	-15.66%	-4.37%	-13.67%

Compare MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
AGL Agilon Health	2.7477 of 5 stars	4.1	2.0	0.0	3.2	0.0	0.6
AIRS AirSculpt Technologies	0.7867 of 5 stars	1.0	3.0	0.0	0.0	5.0	0.0
CDNA CareDx	4.1624 of 5 stars	3.3	1.0	4.2	2.9	0.8	1.9
PNTG The Pennant Group	3.5747 of 5 stars	3.3	3.0	0.0	3.0	2.5	1.9

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
AGL Agilon Health	2.17	Hold	$4.71	121.33% Upside
AIRS AirSculpt Technologies	2.00	Hold	$3.75	-32.55% Downside
CDNA CareDx	2.67	Moderate Buy	$29.33	146.29% Upside
PNTG The Pennant Group	2.60	Moderate Buy	$33.80	44.26% Upside

Current Analyst Ratings Breakdown

Latest AIRS, CDNA, AGL, and PNTG Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
7/18/2025	CDNA CareDx	Craig Hallum Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Buy ➝ Buy	$40.00 ➝ $26.00
7/16/2025	PNTG The Pennant Group	Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Hold ➝ Hold	$32.00 ➝ $28.00
7/9/2025	AGL Agilon Health	Evercore ISI Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	In-Line ➝ In-Line	$5.00 ➝ $3.00
6/10/2025	PNTG The Pennant Group	Stephens Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Overweight ➝ Overweight	$35.00
6/3/2025	PNTG The Pennant Group	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Equal Weight ➝ Equal Weight	$30.00 ➝ $31.00
5/13/2025	AGL Agilon Health	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Overweight ➝ Overweight	$6.00 ➝ $5.00
5/12/2025	PNTG The Pennant Group	Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Hold ➝ Hold	$28.00 ➝ $32.00
5/8/2025	AGL Agilon Health	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Underweight ➝ Underweight	$2.00 ➝ $3.00
5/8/2025	AGL Agilon Health	The Goldman Sachs Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Neutral ➝ Neutral	$2.50 ➝ $5.00
5/5/2025	CDNA CareDx	Stephens Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Overweight ➝ Overweight	$40.00 ➝ $40.00
5/5/2025	CDNA CareDx	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Neutral ➝ Neutral	$25.00 ➝ $25.00

(Data available from 7/21/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
AGL Agilon Health	$6.06B	0.15	N/A	N/A	$1.14 per share	1.87
AIRS AirSculpt Technologies	$180.35M	1.81	$0.17 per share	33.15	$1.37 per share	4.06
CDNA CareDx	$333.79M	1.99	$1.36 per share	8.76	$7.06 per share	1.69
PNTG The Pennant Group	$695.24M	1.16	$0.92 per share	25.41	$9.08 per share	2.58

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
AGL Agilon Health	-$260.15M	-$0.59	N/A	N/A	N/A	-4.04%	-45.47%	-12.76%	8/5/2025 (Estimated)
AIRS AirSculpt Technologies	-$8.25M	-$0.30	N/A	∞	N/A	-9.95%	-15.01%	-5.85%	8/8/2025 (Estimated)
CDNA CareDx	$52.55M	$1.15	10.36	N/A	N/A	19.79%	21.16%	14.25%	7/30/2025 (Estimated)
PNTG The Pennant Group	$22.56M	$0.76	30.83	26.63	1.99	3.40%	10.73%	4.00%	8/5/2025 (Estimated)

Latest AIRS, CDNA, AGL, and PNTG Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
8/8/2025	Q2 2025	AIRS AirSculpt Technologies	$0.02	N/A	N/A	N/A	$45.59 million	N/A
8/5/2025	Q2 2025	AGL Agilon Health	-$0.11	N/A	N/A	N/A	$1.47 billion	N/A
8/5/2025	Q2 2025	PNTG The Pennant Group	$0.26	N/A	N/A	N/A	$210.59 million	N/A
7/30/2025	Q2 2025	CDNA CareDx	$0.12	N/A	N/A	N/A	$90.72 million	N/A
5/6/2025	Q1 2025	AGL Agilon Health	-$0.01	$0.03	+$0.04	$0.03	$1.50 billion	$1.53 billion
4/30/2025	Q1 2025	CDNA CareDx	$0.06	$0.09	+$0.03	-$0.19	$84.56 million	$84.69 million

Compare Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
AGL Agilon Health	N/A	N/A	N/A	N/A	N/A
AIRS AirSculpt Technologies	N/A	N/A	N/A	N/A	N/A
CDNA CareDx	N/A	N/A	N/A	N/A	N/A
PNTG The Pennant Group	N/A	N/A	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
AGL Agilon Health	N/A	1.20	1.20
AIRS AirSculpt Technologies	0.90	0.57	0.57
CDNA CareDx	N/A	4.11	3.84
PNTG The Pennant Group	0.81	1.41	1.41

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
AGL Agilon Health	N/A
AIRS AirSculpt Technologies	91.54%
CDNA CareDx	N/A
PNTG The Pennant Group	85.88%

Insider Ownership

Company	Insider Ownership
AGL Agilon Health	3.57%
AIRS AirSculpt Technologies	76.58%
CDNA CareDx	4.40%
PNTG The Pennant Group	5.40%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
AGL Agilon Health	1,076	413.95 million	399.17 million	Not Optionable
AIRS AirSculpt Technologies	240	58.78 million	13.77 million	Optionable
CDNA CareDx	740	55.68 million	53.23 million	Optionable
PNTG The Pennant Group	7,000	34.47 million	32.61 million	Optionable

AIRS, CDNA, AGL, and PNTG Headlines

Recent News About These Companies

3 Small-Cap Stocks We Think Twice About

July 18 at 9:21 PM | finance.yahoo.com

agilon health, LifeStance Health Group, The Pennant Group, Corcept, and Amphastar Pharmaceuticals Shares Plummet, What You Need To Know

July 18 at 4:20 PM | msn.com

Truist Financial Issues Pessimistic Forecast for The Pennant Group (NASDAQ:PNTG) Stock Price

July 16, 2025 | marketbeat.com

Gold (XAU/USD) Price Forecast: Holds 50-Day MA Amid Pennant Formation

July 15, 2025 | fxempire.comF

Rice Hall James & Associates LLC Boosts Stock Holdings in The Pennant Group, Inc. (NASDAQ:PNTG)

July 14, 2025 | marketbeat.com

The Pennant Group, Inc. (NASDAQ:PNTG) Shares Sold by Teacher Retirement System of Texas

July 14, 2025 | marketbeat.com

The Pennant Group (NASDAQ:PNTG) Stock Price Down 4.7% - What's Next?

July 2, 2025 | marketbeat.com

4 Stocks to Watch in a Rapidly Shifting Outpatient Home Health Space

July 2, 2025 | zacks.com

The Pennant Group, Inc. Expands California Presence with Acquisition of GrandCare Health Services

July 1, 2025 | quiverquant.comQ

Pennant Announces Home Health Acquisition in Southern California

July 1, 2025 | globenewswire.com

The Pennant Group (NASDAQ:PNTG) Shares Gap Down - Here's Why

July 1, 2025 | marketbeat.com

Peregrine Capital Management LLC Trims Stake in The Pennant Group, Inc. (NASDAQ:PNTG)

July 1, 2025 | marketbeat.com

Wells Fargo Increases PT on The Pennant Group Stock, Keeps Equal Weight Rating

July 1, 2025 | insidermonkey.com

Balance Wealth LLC Makes New Investment in The Pennant Group, Inc. (NASDAQ:PNTG)

June 25, 2025 | marketbeat.com

Is There Now An Opportunity In The Pennant Group, Inc. (NASDAQ:PNTG)?

May 30, 2025 | finance.yahoo.com

Joanne Stringfield Sells 5,000 Shares of The Pennant Group, Inc. (NASDAQ:PNTG) Stock

May 24, 2025 | insidertrades.com

Pennant Group holds annual meeting, elects directors

May 21, 2025 | investing.com

PNTG Q1 Earnings Call: Acquisition Momentum and Organic Growth Drive Outperformance

May 20, 2025 | finance.yahoo.com

Pennant Group appoints new board director

May 18, 2025 | investing.com

Additional Considerations Required While Assessing Pennant Group's (NASDAQ:PNTG) Strong Earnings

May 16, 2025 | finance.yahoo.com

The Pennant Group, Inc. Announces Appointment of Suzanne D. Snapper to Board of Directors

May 16, 2025 | quiverquant.comQ

New MarketBeat Followers Over Time

Media Sentiment Over Time

AIRS, CDNA, AGL, and PNTG Company Descriptions

Agilon Health NYSE:AGL

$2.13 -0.04 (-1.84%)

Closing price 07/18/2025 03:59 PM Eastern

Extended Trading

$2.13 0.00 (0.00%)

As of 05:38 AM Eastern

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc. and changed its name to agilon health, inc. in March 2021. agilon health, inc. was founded in 2016 and is based in Austin, Texas.

AirSculpt Technologies NASDAQ:AIRS

$5.56 -0.37 (-6.24%)

Closing price 07/18/2025 04:00 PM Eastern

Extended Trading

$5.56 0.00 (0.00%)

As of 07/18/2025 04:50 PM Eastern

AirSculpt Technologies, Inc., together with its subsidiaries, focuses on operating as a holding company for EBS Intermediate Parent LLC that provides body contouring procedure services in the United States. The company offers AirSculpt, a next-generation body contouring procedure that removes unwanted fat and tightens skin in a minimally invasive procedure. It also provides AirSculpt+, a procedure that permanently removes fat and tightens the skin with unparalleled precision and finesse; and AirSculpt Smooth, an advanced cellulite removal tool. In addition, it provides fat removal procedures across treatment areas, such as the stomach, back, and buttocks; and fat transfer procedures that use the patient's own fat cells to enhance the breasts, buttocks, hips, or other areas. The company's body contouring procedures also include the Power BBL, a Brazilian butt lift procedure; the Up a Cup, a breast enhancement procedure; and the Hip Flip, an hourglass contouring procedure. It operates various centers. The company was founded in 2012 and is headquartered in Miami Beach, Florida.

CareDx NASDAQ:CDNA

$11.91 +0.10 (+0.85%)

Closing price 07/18/2025 04:00 PM Eastern

Extended Trading

$12.14 +0.23 (+1.97%)

As of 06:12 AM Eastern

CareDx, Inc. engages in the discovery, development, and commercialization of diagnostic solutions for transplant patients and caregivers in the United States and internationally. It also provides AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution for heart transplant patients; and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. The company offers Olerup SSP, which is used to type human leukocyte antigen (HLA) alleles based on sequence specific primer technology; QTYPE that enables precision in HLA typing; and Ottr, a transplant patient management software. In addition, it provides AlloSeq Tx, a high-resolution HLA typing solution; AlloSeq cfDNA, a surveillance solution to measure dd-cfDNA in blood; AlloSeq HCT, a solution for chimerism testing for stem cell transplant recipients; Allocell, a surveillance solution that monitors the level of engraftment and persistence of allogeneic cells for patients who have received cell therapy transplants; and XynQAPI cloud-based transplant quality management software, as well as AlloCare, a mobile app that offers a patient-centric resource for transplant recipients. The company offers its products directly to customers, as well as through third-party distributors and sub-distributors. It has a license agreement with Illumina, Inc. for the distribution, development, and commercialization of NGS products and technologies; and Cibiltech SAS to commercialize iBox, a software for the predictive analysis of post-transplantation kidney allograft loss. The company was formerly known as XDx, Inc. and changed its name to CareDx, Inc. in March 2014. The company was incorporated in 1998 and is headquartered in South San Francisco, California.

The Pennant Group NASDAQ:PNTG

$23.43 -0.48 (-2.01%)

Closing price 07/18/2025 04:00 PM Eastern

Extended Trading

$23.43 0.00 (0.00%)

As of 04:53 AM Eastern

The Pennant Group, Inc. provides healthcare services in the United States. It operates in two segments, Home Health and Hospice Services, and Senior Living Services. The company offers home health services, including clinical services, such as nursing, speech, occupational and physical therapy, medical social work, and home health aide services; and hospice services comprising clinical care, education, and counseling services for the physical, spiritual, and psychosocial needs of terminally ill patients and their families. It also provides senior living services, such as residential accommodations, activities, meals, housekeeping, and assistance in the activities of daily living to seniors who are independent or who require some support. The company operates home health, hospice, and home care agencies, as well as senior living communities throughout Arizona, California, Colorado, Idaho, Montana, Nevada, Oklahoma, Oregon, Texas, Utah, Washington, Wisconsin, and Wyoming. The Pennant Group, Inc. was incorporated in 2019 and is headquartered in Eagle, Idaho.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time